Genetic Testing Blood Tests Drug Testing Genetic Screening Genetics Blood Testing MRI Diagnostic Procedures Chromosome Analysis Gender Testing PSA Testing Cognitive Testing Toxicology Blood Test Concussion Testing Blood Analysis Diagnostic Tests Neurological Health Athlete Health Examinations Diagnosis Chromosomal Testing Cancer Screening Respiratory Diseases DNA Testing Medical Decisions Imaging Tests HIV/STI Testing Urine Analysis THC Detection Autopsy Sports Health Forensic Medicine Screening Tests Sex Screening Genetic Conditions Sex Testing Substance Testing Food Intolerance Hormones Hormonal Conditions Standardized Tests Examination Results Preventative Care Gender Verification Pregnancy Tests Gender Identity Pregnancy Lateral Flow Tests Liver Function Tests Liver Health Precision Medicine Biopsy Nutritional Testing Biological Analysis Neurological Testing Concussions Neurology Alcohol Metabolism Concussion Protocols Cancer Detection PCR Testing Muscle Imbalance Liquid Biopsy Whole Genome Sequencing Diagnostics Provider Patient Safety Diagnostic Imaging Meningitis Testing Genomic Testing Scans Antigen Tests Hormonal Levels Chromosomal Analysis Evaluation Illness Evaluation HIV Testing Chromosomal Conditions Elbow Discomfort Social Media Influence Noninvasive Procedures Seizure Disorders Urine and Blood Testing STD Testing Diagnostic Testing COVID-19 Detection
The missed endpoint leaves FDA review uncertain alongside potential Medicare coverage.
